作为降脂试验结果衡量指标的相对风险降低率与需治疗人数

Am J Cardiol. 1998 Aug 15;82(4):505-7. doi: 10.1016/s0002-9149(98)00367-1.

Recent clinical trials dealing with cholesterol reduction in primary and secondary prevention for cardiovascular disease use Relative Risk Reduction to assess their clinical outcomes. Number Needed to Treat is a more valid measurement.

近期关于心血管疾病一级和二级预防中降低胆固醇的临床试验使用相对风险降低率来评估其临床结果。需治疗人数是一种更有效的衡量指标。